Literature DB >> 17275373

QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.

Chunyan Zhao1, Haixia Zhang, Feng Luan, Ruisheng Zhang, Mancang Liu, Zhide Hu, Botao Fan.   

Abstract

The support vector machine (SVM), which is a novel algorithm from the machine learning community, was used to develop quantitative structure-activity relationship (QSAR) models for predicting the binding affinity of 152 nonapeptides, which can bind to class I MHC HLA-A*201 molecule. Each peptide was represented by a large pool of descriptors including constitutional, topological descriptors and physical-chemical properties. The heuristic method (HM) was then used to search the descriptor space for selecting the proper ones responsible for binding affinity. The four descriptors were obtained to build linear models based on HM and nonlinear models based on SVM method. The best results are found using SVM: root mean-square (RMS) errors for training, test and whole data set were 0.383, 0.385 and 0.384, respectively. This paper allow the prediction of the binding affinity of new, untested peptides and, through the analysis of contribution of each parameter of different residue at specific position of peptidic ligands, to understand nature of the forces governing binding behavior and suggest new ideas for further synthesis of high-affinity peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17275373     DOI: 10.1016/j.jmgm.2006.12.002

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  3 in total

Review 1.  Current mathematical methods used in QSAR/QSPR studies.

Authors:  Peixun Liu; Wei Long
Journal:  Int J Mol Sci       Date:  2009-04-29       Impact factor: 6.208

2.  An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics.

Authors:  Robert D Bremel; E Jane Homan
Journal:  Immunome Res       Date:  2010-11-02

Review 3.  Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope.

Authors:  Arathi Kizhedath; Simon Wilkinson; Jarka Glassey
Journal:  Arch Toxicol       Date:  2016-10-20       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.